RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States
Subtitle: hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994.
Publisher: U.S. G.P.O.; For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Published: 1994
Place of publication: Washington
Number of pages: 48
Subjects: Mifepristone -- Government policy -- United States.; Progesterone -- Antagonists -- Government policy -- United States.; Pharmaceutical policy -- United States.